More on FDA’s EUA for Hydroxychloroquine Sulfate and Chloroquine Phosphate
Here’s what Eagle’s Chief Technical Officer and the current Chairman of the USP Microbiology Expert Committee, Dr. David Hussong says about the Emergency Use Authorization (EUA) of hydroxychloroquine sulfate and chloroquine phosphate issued by the FDA on March 29, 2020.
More details on the EUA are available in this article.
Eagle is an FDA and DEA registered, A2LA ISO 17025 accredited laboratory providing analytical and microbiological testing services along with expert consulting services to 503A compounding pharmacies, 503B outsourcing facilities, and pharmaceutical companies.
Latest posts by Eagle Analytical (see all)
- Central Drug Compounding & Wellness Recommends Eagle Plates - April 16, 2021
- Paperless Sample Submissions – Effective May 3, 2021 - April 8, 2021
- The Woodlands Compounding Pharmacy Recommends Eagle Plates - April 7, 2021
